Conexiant
Login
  • The Analytical Scientist
  • The Cannabis Scientist
  • The Medicine Maker
  • The Ophthalmologist
  • The Pathologist
  • The Traditional Scientist
The Analytical Scientist
  • Explore

    Explore

    • Latest
    • News & Research
    • Trends & Challenges
    • Keynote Interviews
    • Opinion & Personal Narratives
    • Product Profiles
    • App Notes
    • The Product Book

    Featured Topics

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy

    Issues

    • Latest Issue
    • Archive
  • Topics

    Techniques & Tools

    • Mass Spectrometry
    • Chromatography
    • Spectroscopy
    • Microscopy
    • Sensors
    • Data and AI

    • View All Topics

    Applications & Fields

    • Clinical
    • Environmental
    • Food, Beverage & Agriculture
    • Pharma and Biopharma
    • Omics
    • Forensics
  • People & Profiles

    People & Profiles

    • Power List
    • Voices in the Community
    • Sitting Down With
    • Authors & Contributors
  • Business & Education

    Business & Education

    • Innovation
    • Business & Entrepreneurship
    • Career Pathways
  • Events
    • Live Events
    • Webinars
  • Multimedia
    • Video
    • Content Hubs
Subscribe
Subscribe

False

The Analytical Scientist / Issues / 2026 / March / A Closer Look at Vascular Cell States in Marfan Syndrome
Omics Translational Science Omics

A Closer Look at Vascular Cell States in Marfan Syndrome

Single-cell proteomics identifies Marfan-enriched smooth muscle states and endothelial transition signatures

03/25/2026 2 min read

Share

A label-free single-cell proteomics workflow has revealed previously unresolved vascular cell states in Marfan syndrome, offering a closer look at how aneurysm-associated changes vary across the aortic wall.

In the study, researchers profiled individual cells isolated from the aortic roots of wild-type and Fbn1C1041G/+ mice, a widely used model of Marfan syndrome. The analysis captured nearly 5,000 cells, with 3,475 retained for downstream analysis, and identified major aortic cell types, including endothelial cells, fibroblasts, macrophages, and multiple smooth muscle cell populations.

To capture those differences, the researchers turned to a direct liquid chromatography–mass spectrometry workflow tailored for single-cell proteomics. By avoiding multiplexed labeling strategies, the method aimed to improve quantitative accuracy and preserve protein-level differences between individual cells.

Clustering of the proteomic data identified 16 cell groups overall, including seven distinct smooth muscle cell subtypes. These ranged from more contractile states to more modified phenotypes, helping the researchers resolve heterogeneity that is difficult to capture with bulk tissue analysis.

Several of the altered smooth muscle cell states were more abundant in Marfan tissue. In particular, the researchers identified disease-enriched subpopulations marked by proteins including LRP1 and PRSS2, suggesting shifts in smooth muscle phenotype during aneurysm development. The analysis also pointed to changes in endothelial cells consistent with endothelial-to-mesenchymal transition, including reduced abundance of adhesion-associated proteins alongside increased expression of smooth muscle-related markers.

To test whether these signals could be confirmed in tissue, the team performed multiplexed spatial proteomics on independent mouse samples. These experiments supported the presence and tissue localization of key Marfan-associated markers, including PRSS2-positive smooth muscle cells and endothelial populations showing transition-like features.

Comparison with published single-cell RNA sequencing datasets showed that transcriptomic and proteomic data agreed well for broad cell classes, but less so for finer smooth muscle subtypes. When the two datasets were analyzed together, the researchers identified additional Marfan-associated cell states, including ACE- and TPM4-linked clusters, suggesting that some phenotypic differences were not fully resolved by RNA data alone.

In their discussion, the authors suggest that these newly defined smooth muscle populations now warrant closer functional study, particularly to determine whether markers such as LRP1 and PRSS2 reflect pathogenic remodeling or compensatory responses in Marfan aneurysm progression.

Newsletters

Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.

Newsletter Signup Image

False

Advertisement

Recommended

False

Related Content

The Analytical Scientist Innovation Awards 2024: #7
Omics
The Analytical Scientist Innovation Awards 2024: #7

December 2, 2024

4 min read

Frank Steemers, co-founder and CSO of Scale Biosciences, tells us the story of ScalePlex – the 7th ranked innovation on this year’s Awards

The Analytical Scientist Innovation Awards 2024: #4
Omics
The Analytical Scientist Innovation Awards 2024: #4

December 5, 2024

6 min read

Thermo Fisher Scientific’s high-sensitivity mass spec for translational omics research – the Stellar MS – is ranked 4th in our annual Innovation Awards

Let Me See That Brain
Omics
Let Me See That Brain

December 9, 2024

1 min read

TRISCO sets a new standard for 3D RNA imaging, delivering high-resolution and uniform images to offer insights into brain function and anatomy

The Analytical Scientist Innovation Awards 2024
Omics
The Analytical Scientist Innovation Awards 2024

December 11, 2024

10 min read

Meet the products – and the experts – defining analytical innovation in 2024

False

The Analytical Scientist
Subscribe

About

  • About Us
  • Work at Conexiant Europe
  • Terms and Conditions
  • Privacy Policy
  • Advertise With Us
  • Contact Us

Copyright © 2026 Texere Publishing Limited (trading as Conexiant), with registered number 08113419 whose registered office is at Booths No. 1, Booths Park, Chelford Road, Knutsford, England, WA16 8GS.